Prime Medicine, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Equivalents | $63.0M | $182.5M | $41.6M | $187.6M | $185.4M | $37.0M | $8.6M |
| Accounts Receivable | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — |
| Total Current Assets | $181.3M | $211.9M | $143.0M | $296.6M | $270.6M | — | — |
| Property, Plant & Equipment | $20.6M | $24.4M | $22.7M | $19.0M | $4.9M | — | — |
| Goodwill | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — |
| Total Assets | $342.7M | $297.5M | $193.9M | $360.3M | $301.9M | — | — |
| Liabilities | |||||||
| Accounts Payable | $8.9M | $11.4M | $19.5M | $4.3M | $1.4M | — | — |
| Total Current Liabilities | $37.4M | $38.0M | $56.4M | $26.7M | $58.0M | — | — |
| Long-Term Debt | — | — | — | — | — | — | — |
| Total Liabilities | $221.9M | $144.4M | $60.8M | $44.0M | $62.3M | — | — |
| Stockholders' Equity | |||||||
| Retained Earnings | $-888.4M | $-687.2M | $-491.3M | $-293.2M | $-171.4M | — | — |
| Total Stockholders' Equity | $120.9M | $153.1M | $133.1M | $316.3M | $-156.2M | $2.3M | $-2.6M |